RxPrep

The treatment algorithm was modified: Metformin and lifestyle modifications are still first-line, but for dual therapy, clinical ASCVD should be considered before selecting an agent. If ASCVD is present, choose liraglutide, empagliflozin, or canagliflozin; these drugs reduce the risk of major cardiovascular events in patients with diabetes and ... ................
................